2020年6月16日 (二) 6:00 - 8:00 PM |
Dinner Short Course 1: Sample Prep Technologies
Dave Alburty, CEO, Engineering, InnovaPrep
James Brayer, Associate Director, Market Development, Oxford Nanopore Technologies
Venkateswaran Kodumudi, PhD, Chief Scientist, Tetracore
What are the questions to ask when going into a sampling campaign? Strategies and tactics for sampling will be explored and developments discussed that contribute to the determination of a plan and a campaign. Available technologies for sampling, sample prep, and identification will be presented and hands-on demonstrations will illustrate some of the principles involved. Case studies will illustrate the challenges faced in plan execution.
Mr. Alburty has thirty years of experience in environmental monitoring and biosurveillance. Beginning at Midwest Research Institute (MRIGlobal) in Kansas City his work as a staff research scientist centered on aerosol studies in environmental and biodefense applications. After serving fifteen years at MRI, Dave founded an aerosol science and engineering R&D test and evaluation/product development lab. Subsequently, he founded a product development engineering company seeking to make the world a better and safer place.
James Brayer is an Associate Director of Market Development at Oxford Nanopore Technologies, Inc. (ONT). He received his B.A. from Colby College. Mr. Brayer has over 30 years of cumulative experience in the Life Science and OMICS markets holding roles in market development, sales, marketing, technical sales, scientific support and basic research. James was one of the first members of the ONT commercial team. Led by his passion to help his customers utilize Oxford Nanopore's 'Nanopore Sensing' technology, James is focused on building awareness through public speaking, engaging with customers on novel and existing applications. James had the privilege to be directly involved with NASA's Biomolecule Sequencer Project to send the first MinION to the International Space Station and perform the first ever NGS sequencing in a zero gravity environment. He loves to discuss this project with anyone interested in learning more about it. He currently is a member of ONTs global market development team focusing on finding new market segments to utilize ONT's nanopore sequencing platform.
2020年6月16日 (二) 6:00 - 8:00 PM |
Dinner Short Course 2: Rapid Vaccine Technologies
Willy Valdivia-Granda, Founder & CEO, Orion Integrated Biosciences, Inc.
The need for the rapid formulation of novel vaccines in response to emerging pathogens is critical to public health and safety. The vaccines developed should elicit protective immune responses and be unaffected by pre-existing immunity to vaccine components. In addition, these treatments should be amenable to combination and multi-agent formulation, and should be safe for all populations and the environment.
Topics to be covered include:
- Status of Vaccines for Ebola
- Vaccines for Bacterial Pathogens
- Advances in Rational Vaccine Design and Development Role of Adjuvants in Developing More Effective Vaccines
- Veterinary Vaccines and New Generation of the DIVA-Concept
- Advances in Vaccine Manufacturing
- Strategies for Vaccine Licensing
- FDA's Regulatory Policy
- Initiatives for Funding Vaccine Development Government Vaccine Portfolio
Willy A. Valdivia is the founder and CEO of Orion Integrated Biosciences, Inc., where he heads a team of experts in genomics, computational biology, data analytics, and artificial intelligence. Since 2003, his efforts have focused on the implementation of algorithms for the development of medical countermeasures against known and unknown biothreats. Supported by DHS-S&T-OUP, DHS-CBP, DoD, DTRA, USDA, NIH and the EU, Mr. Valdivia has a broad view of innovation and technology development for biodefense. In 2014 Mr. was named one of the four most successful Latin-American bio-entrepreneurs by the Spanish Bioindustry Association (ASEBIO). Currently, he leads or participates in sectors to support national security including a close collaboration the DHS Centers of Excellence. Willy Valdivia is the author of publications on data mining, genomics of infectious diseases, and bioterrorism and four book chapters on national security and policy. He serves as a subject matter expert for the US government and the European Commission and has active research projects in the US, Europe, and Africa, and Latin-America.